Lava Medtech Acquisition Stock Current Valuation
| LVACUDelisted Stock | USD 10.40 0.00 0.00% |
Valuation analysis of Lava Medtech Acquisition helps investors to measure Lava Medtech's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Lava Medtech's price fluctuation is very steady at this time. Calculation of the real value of Lava Medtech Acquisition is based on 3 months time horizon. Increasing Lava Medtech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Lava Medtech's intrinsic value may or may not be the same as its current market price of 10.40, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10.4 | Real 8.84 | Hype 10.4 | Naive 10.4 |
The intrinsic value of Lava Medtech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Lava Medtech's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Lava Medtech Acquisition helps investors to forecast how Lava stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Lava Medtech more accurately as focusing exclusively on Lava Medtech's fundamentals will not take into account other important factors: Lava Medtech Acquisition Company Current Valuation Analysis
Lava Medtech's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Lava Medtech Acquisition has a Current Valuation of 0.0. This is 100.0% lower than that of the Financial Services sector and about the same as Shell Companies (which currently averages 0.0) industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Lava Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lava Medtech's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Lava Medtech could also be used in its relative valuation, which is a method of valuing Lava Medtech by comparing valuation metrics of similar companies.Lava Medtech is currently under evaluation in current valuation category among its peers.
Lava Fundamentals
| Return On Asset | -0.0081 | |||
| Shares Owned By Institutions | 10.18 % | |||
| Number Of Shares Shorted | 105 | |||
| EBITDA | (6.22 M) | |||
| Net Income | 4.5 M | |||
| Cash And Equivalents | 1.15 M | |||
| Cash Per Share | 0.08 X | |||
| Total Debt | 92.81 K | |||
| Debt To Equity | 4.92 % | |||
| Current Ratio | 18.29 X | |||
| Book Value Per Share | (0.21) X | |||
| Cash Flow From Operations | (658.82 K) | |||
| Short Ratio | 1.88 X | |||
| Total Asset | 120.67 M | |||
| Retained Earnings | (3.01 M) | |||
| Working Capital | (3.39 M) | |||
| Z Score | -0.24 | |||
| Net Asset | 120.67 M |
About Lava Medtech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Lava Medtech Acquisition's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lava Medtech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lava Medtech Acquisition based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Lava Stock
If you are still planning to invest in Lava Medtech Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lava Medtech's history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |